ArticleScientific reports2025
Reduced graphene oxide promoted by SnO
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reduced graphene oxide, with a high specific surface area and conductivity, also exhibits photocatalytic activity, and its photocatalytic performance improves with the addition of semiconductors. In this study, SnO2/reduced graphene oxide (RGO) composite was applied for tetracycline removal from water under visible light irradiation. The photocatalytic performance of RGO was enhanced through SnO2 deposition. RGO was synthesized using Hummer’s method and subsequently impregnated with SnCl2 solution to deposit SnO2. The effect of SnO2 loading was investigated, and the calcination temperature was set at 400 °C. FTIR, XRD, Raman spectroscopy, SEM, TEM, BET, PL, and DRS analyses characterized the SnO2/RGO photocatalyst. SEM and TEM confirmed RGO layered morphology. PL analysis revealed an electron-hole recombination peak at 394 nm. DRS results showed a reduction in the band gap of SnO2/RGO composite compared to pristine SnO2 and RGO. The effects of photocatalyst dosage, initial tetracycline concentration, and pH were studied and optimized using Design-Expert software (version 11) to maximize degradation efficiency. Under optimized conditions, with a tetracycline concentration of 10 mg/L, catalyst dosage of 4 g/L, pH of 7, and 10 min exposure to a 125 W LED lamp, 92% degradation was achieved. Kinetic analysis followed a second-order rate model. The reusability and regenerability of the SnO2/RGO composite were evaluated over five cycles, yielding tetracycline removal efficiencies of 91%, 73.25%, 65.7%, 60.3%, and 57%, respectively. Tetracycline removal was further assessed in the presence of Na+, Cl−, Mg2+, and NO3−, as well as using tap water. Compared with previous studies, this system demonstrated comparable removal efficiency within a substantially shorter reaction time under visible light irradiation, underscoring its economic potential for water treatment applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.